Michael Shawn Moran - Jan 7, 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
EVP, Chief Commercial Officer
Signature
/s/ Brian Cahill, Attorney-in-Fact
Stock symbol
EGRX
Transactions as of
Jan 7, 2022
Transactions value $
-$4,557
Form type
4
Date filed
1/11/2022, 03:42 PM
Previous filing
Jan 7, 2022
Next filing
Feb 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability -$4.56K -90 -0.4% $50.63 22.7K Jan 7, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy withholding tax obligations.